The report provides value (USD million), volume (units) and average price (USD) data for each sector and sub-segment within five industry categories – Diagnostic Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints and Voice Prosthesis. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants with data on company key figures and new product development, wherever available.


Scope of the Research

- Industry size and market share data for ENT Devices industry categories – Diagnostic Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints and Voice Prosthesis.
- Annualized industry revenues (USD million), volume (units) and average price (USD) data for each of the sectors and sub-segments within five industry categories. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the five industry categories.
- Global corporate-level profiles of key industry players operating within the United States ENT Devicesmarket.
- Key Companies covered include Starkey Laboratories, Inc., William Demant Holding A/S, Sonova Holding AG, Cochlear Limited, Siemens Healthcare, Widex A/S and others.

Why Should You Get This Report?

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the United States ENT Devices competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Table Of Contents

1 Table of Contents

I Table of Contents 2
I. 1 List of Data tables 7
I. 2 List of Charts 9

II Introduction 11
II. 1 About this Report and the Author 11

III ENT Devices In United States 12
III. 1 ENT Devices, March ket Segmentation 12
III. 2 ENT Devices, United States, Overall Sales (USD Million), from 2003 to 2017 13
III. 3 ENT Devices March ket, United States, Sales Mix (USD Million), 2010 15
III. 4 ENT Devices March ket, United States, Segment Contribution (%), 2010 16
III. 5 ENT Devices, United States, Segment Volume (Units), from 2003 to 2017 22
III. 6 ENT Devices, United States, Market Shares (2009-2010) 27

IV Diagnostic Devices In United States 29
IV. 1 Diagnostic Devices, March ket Segmentation 29
IV. 2 Diagnostic Devices March ket, United States, Sales Mix (USD Million), 2010 30
IV. 3 Diagnostic Devices March ket, United States, Segment Contribution (%), 2010 31
IV. 4 Diagnostic Devices Overall Sales (2003-2017) 32
IV. 4.1 Otoscopes Sales (2003-2017) 36
IV. 5 Diagnostic Devices Overall Volume (2003-2017) 40
IV. 5.1 Otoscopes Volume (2003-2017) 44
IV. 6 Diagnostic Devices Average Price (2003-2017) 47
IV. 7 Diagnostic Devices Distribution Channel (2009-2010) 48
IV. 8 Diagnostic Devices, United States, Market Shares (2009-2010) 49

V Hearing Aid Devices In United States 50
V. 1 Hearing Aid Devices, March ket Segmentation 50
V. 2 Hearing Aid Devices March ket, United States, Sales Mix (USD Million), 2010 51
V. 3 Hearing Aid Devices March ket, United States, Segment Contribution (%), 2010 52
V. 4 Hearing Aid Devices Overall Sales (2003-2017) 53
V. 4.1 Digital Signal Processing Hearing Aids Sales (2003-2017) 57
V. 5 Hearing Aid Devices Overall Volume (2003-2017) 61
V. 5.1 Digital Signal Processing Hearing Aids Volume (2003-2017) 65
V. 6 Hearing Aid Devices Average Price (2003-2017) 69
V. 7 Hearing Aid Devices Distribution Channel (2009-2010) 70
V. 8 Hearing Aid Devices, United States, Market Shares (2009-2010) 71

VI Hearing Implants In United States 73
VI. 1 Hearing Implants, March ket Segmentation 73
VI. 2 Hearing Implants March ket, United States, Sales Mix (USD Million), 2010 74
VI. 3 Hearing Implants March ket, United States, Segment Contribution (%), 2010 75
VI. 4 Hearing Implants Overall Sales (2003-2017) 76
VI. 5 Hearing Implants Overall Volume (2003-2017) 80
VI. 6 Hearing Implants Average Price (2003-2017) 83
VI. 7 Hearing Implants Distribution Channel (2009-2010) 84
VI. 8 Hearing Implants, United States, Market Shares (2009-2010) 85

VII Nasal Splints In United States 86
VII. 1 Nasal Splints Overall Sales (2003-2017) 86
VII. 2 Nasal Splints Overall Volume (2003-2017) 88
VII. 3 Nasal Splints Average Price (2003-2017) 90
VII. 4 Nasal Splints Distribution Channel (2009-2010) 91

VIII Voice Prosthesis In United States 92
VIII. 1 Voice Prosthesis Overall Sales (2003-2017) 92
VIII. 2 Voice Prosthesis Overall Volume (2003-2017) 94
VIII. 3 Voice Prosthesis Average Price (2003-2017) 96
VIII. 4 Voice Prosthesis Distribution Channel (2009-2010) 97
VIII. 5 Voice Prosthesis, United States, Market Shares (2009-2010) 98

IX Overview of Key Firms in United States ENT Devices March ket 99
IX. 1 Starkey Laboratories, Inc. 99
IX. 1.1 Company Profile 99
IX. 1.2 Share in the United States ENT Devices March ket 99
IX. 2 William Demant Holding A/S 100
IX. 2.1 Company Profile 100
IX. 2.2 Share in the United States ENT Devices March ket 100
IX. 3 Sonova Holding AG 101
IX. 3.1 Company Profile 101
IX. 3.2 Share in the United States ENT Devices March ket 101
IX. 4 Cochlear Limited 102
IX. 4.1 Company Profile 102
IX. 4.2 Share in the United States ENT Devices March ket 102
IX. 5 Siemens Healthcare 103
IX. 5.1 Company Profile 103
IX. 5.2 Share in the United States ENT Devices March ket 103
IX. 6 Widex A/S 104
IX. 6.1 Company Profile 104
IX. 6.2 Share in the United States ENT Devices March ket 104
IX. 7 GN ReSound A/S 105
IX. 7.1 Company Profile 105
IX. 8 MED-EL 105
IX. 8.1 Company Profile 105
IX. 9 Welch Allyn Inc. 105
IX. 9.1 Company Profile 105
IX. 10 Neurelec 105
IX. 10.1 Company Profile 105
IX. 11 Atos Medical AB 106
IX. 11.1 Company Profile 106

X ENT Devices March ket Pipeline Products 107

XI Financial Deals Landscape 108
XI. 1 Acquisition 108
XI. 1.1 Synthes Takes Over the Anspach Effort 108
XI. 1.2 Cascade Technologies To Take Over AcuNetx 109
XI. 1.3 Stryker Takes Over Porex Surgical 110
XI. 1.4 GN ReSound Increases Proposal To Take Over Otix World 111
XI. 1.5 William Demant Completes Acquisition Of Otix World 112
XI. 2 Partner agreements 114
XI. 2.1 HemCon Medical Technologies Concludes a New Deal With ENTrigue Surgical 114
XI. 2.2 Integral Technologies Enters Into Licensing Agreement For ElectriPlast Technology 115

XII Recent Developments 116
XII. 1 Company Vision and Strategy 116
XII. 1.1 April 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 116
XII. 2 Legal and Regulatory 116
XII. 2.1 March 17, 2011: HearUSA Responds To Siemens Filing 116
XII. 2.2 February 17, 2011: Entellus Medical Settles Patent Dispute 117
XII. 2.3 February 09, 2011: ArthroCare Announces Settlement Of SEC Investigation 117
XII. 2.4 February 04, 2011: HearUSA Files Suit Against Siemens 117
XII. 2.5 June 09, 2010: Cochlear Americas Agrees To Pay US$ 880,000 To Resolve Fraud Allegations 118
XII. 2.6 June 04, 2010: Cochlear Settles Agreement With DOJ And OIG 118
XII. 3 Government and Public Interest 119
XII. 3.1 January 12, 2011: Northwestern Memorial Hospital Participates In Hybrid Cochlear Implant Study 119
XII. 3.2 November 10, 2010: Pediatric And Adult ENTs Perform New Procedure To Remove Salivary Stones 119
XII. 3.3 October 22, 2010: Clinilabs Selected For Study To Test Effects Of Vestibular Stimulation On Chronic Insomnia 120
XII. 3.4 September 02, 2010: NCBH Launches Hearing Health Web Site 120
XII. 3.5 August 17, 2010: Hearing Loss In US Adolescents More Prevalent: JAMA Study 121
XII. 3.6 June 30, 2010: New Cochlear Implant Could Improve Outcomes For Patients: Medical College Of Georgia 121
XII. 3.7 June 23, 2010: Ear Tubes Appear Safe In Children With Cochlear Implants: UAB Study 122
XII. 3.8 May 12, 2010: AuDNet And Oaktree Products Join Forces To Offer Hearing Protection Devices In US 123
XII. 3.9 April 20, 2010: Cochlear Implantation In Deaf Kids At Younger Age Helps Improve Ability To Hear And Speak 124
XII. 4 Product News 125
XII. 4.1 April 19, 2010: Entellus Medical Wins 2010 Medical Design Excellence Award For FinESS Sinus Treatment 125

XIII Appendix 126
XIII. 1 Definitions of March kets Covered in the Report 127
XIII. 1.1 ENT Devices 127
XIII. 2 Research Methodology 129
XIII. 3 Secondary Research 129
XIII. 4 Primary Research 130
XIII. 5 Models 130
XIII. 6 Forecasted data s 131
XIII. 7 Expert Panels 131
XIII. 8 GlobalData Consulting 131
XIII. 9 Currency Conversion 131
XIII. 10 Contact Us 132
XIII. 11 Disclaimer 132

1.1 List of Data tables
Data table 1: ENT Devices, United States, Overall Sales (USD Million), from 2003 to 2017 14
Data table 2: ENT Devices March ket, United States, Segment Contribution (%), 2010 16
Data table 3: ENT Devices, United States, Cross-Category Analysis, from 2003 to 2017 17
Data table 4: ENT Devices, United States, Overall Sales (USD Million), Historical data, from 2003 to 2010 19
Data table 5: ENT Devices, United States, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 21
Data table 6: ENT Devices, United States, Segment Volume (Units), from 2003 to 2017 22
Data table 7: ENT Devices, United States, Segment Volume (Units), Historical data, from 2003 to 2010 24
Data table 8: ENT Devices, United States, Segment Volume (Units), Forecasted data, from 2010 to 2017 26
Data table 9: ENT Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 28
Data table 10: Diagnostic Devices March ket, United States, Segment Contribution (%), 2010 31
Data table 11: Diagnostic Devices, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 33
Data table 12: Diagnostic Devices, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 35
Data table 13: Otoscopes, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 37
Data table 14: Otoscopes, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 39
Data table 15: Diagnostic Devices, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 41
Data table 16: Diagnostic Devices, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 43
Data table 17: Otoscopes, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 45
Data table 18: Otoscopes, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 46
Data table 19: Diagnostic Devices, United States, Average Price ($), Historical data, from 2003 to 2010 47
Data table 20: Diagnostic Devices, United States, Average Price ($), Forecasted data, from 2010 to 2017 47
Data table 21: Diagnostic Devices, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 48
Data table 22: Diagnostic Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 49
Data table 23: Hearing Aid Devices March ket, United States, Segment Contribution (%), 2010 52
Data table 24: Hearing Aid Devices, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 54
Data table 25: Hearing Aid Devices, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 56
Data table 26: Digital Signal Processing Hearing Aids, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 58
Data table 27: Digital Signal Processing Hearing Aids, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 60
Data table 28: Hearing Aid Devices, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 62
Data table 29: Hearing Aid Devices, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 64
Data table 30: Digital Signal Processing Hearing Aids, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 66
Data table 31: Digital Signal Processing Hearing Aids, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 68
Data table 32: Hearing Aid Devices, United States, Average Price ($), Historical data, from 2003 to 2010 69
Data table 33: Hearing Aid Devices, United States, Average Price ($), Forecasted data, from 2010 to 2017 69
Data table 34: Hearing Aid Devices, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 70
Data table 35: Hearing Aid Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 72
Data table 36: Hearing Implants March ket, United States, Segment Contribution (%), 2010 75
Data table 37: Hearing Implants, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 77
Data table 38: Hearing Implants, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 79
Data table 39: Hearing Implants, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 81
Data table 40: Hearing Implants, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 82
Data table 41: Hearing Implants, United States, Average Price ($), Historical data, from 2003 to 2010 83
Data table 42: Hearing Implants, United States, Average Price ($), Forecasted data, from 2010 to 2017 83
Data table 43: Hearing Implants, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 84
Data table 44: Hearing Implants, United States, Market Shares by Sales (USD Million), from 2009 to 2010 85
Data table 45: Nasal Splints, United States, Sales (USD Million), Historical data, from 2003 to 2010 86
Data table 46: Nasal Splints, United States, Sales (USD Million), Forecasted data, from 2010 to 2017 87
Data table 47: Nasal Splints, United States, Volume (Units), Historical data, from 2003 to 2010 88
Data table 48: Nasal Splints, United States, Volume (Units), Forecasted data, from 2010 to 2017 89
Data table 49: Nasal Splints, United States, Average Price ($), Historical data, from 2003 to 2010 90
Data table 50: Nasal Splints, United States, Average Price ($), Forecasted data, from 2010 to 2017 90
Data table 51: Nasal Splints, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 91
Data table 52: Voice Prosthesis, United States, Sales (USD Million), Historical data, from 2003 to 2010 92
Data table 53: Voice Prosthesis, United States, Sales (USD Million), Forecasted data, from 2010 to 2017 93
Data table 54: Voice Prosthesis, United States, Volume (Units), Historical data, from 2003 to 2010 94
Data table 55: Voice Prosthesis, United States, Volume (Units), Forecasted data, from 2010 to 2017 95
Data table 56: Voice Prosthesis, United States, Average Price ($), Historical data, from 2003 to 2010 96
Data table 57: Voice Prosthesis, United States, Average Price ($), Forecasted data, from 2010 to 2017 96
Data table 58: Voice Prosthesis, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 97
Data table 59: Voice Prosthesis, United States, Market Shares by Sales (USD Million), from 2009 to 2010 98
Data table 60: ENT Devices March ket Pipeline Products 107
Data table 61: Synthes Takes Over The Anspach Effort 108
Data table 62: Cascade Technologies To Take Over AcuNetx 109
Data table 63: Stryker Takes Over Porex Surgical 110
Data table 64: GN ReSound Increases Proposal To Take Over Otix World 111
Data table 65: William Demant Completes Acquisition Of Otix World 112
Data table 66: HemCon Medical Technologies Concludes a New Deal With ENTrigue Surgical 114
Data table 67: Integral Technologies Enters Into Licensing Agreement For ElectriPlast Technology 115
Data table 68: US Dollar to Local Currency, United States, Average Actual Rate from 2003 to 2010 131

1.2 List of Charts

Chart 1: ENT Devices, March ket Segmentation 12
Chart 2: ENT Devices, United States, Overall Sales (USD Million), from 2003 to 2017 13
Chart 3: ENT Devices March ket, United States, Sales Mix (USD Million), 2010 15
Chart 4: ENT Devices March ket, United States, Segment Contribution (%), 2010 16
Chart 5: ENT Devices, United States, Cross-Category Analysis, from 2003 to 2017 17
Chart 6: ENT Devices, United States, Overall Sales (USD Million), Historical data, from 2003 to 2010 18
Chart 7: ENT Devices, United States, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 20
Chart 8: ENT Devices, United States, Segment Volume (Units), from 2003 to 2017 22
Chart 9: ENT Devices, United States, Segment Volume (Units), Historical data, from 2003 to 2010 23
Chart 10: ENT Devices, United States, Segment Volume (Units), Forecasted data, from 2010 to 2017 25
Chart 11: ENT Devices, United States, Market Shares (%), 2010 27
Chart 12: Diagnostic Devices, March ket Segmentation 29
Chart 13: Diagnostic Devices March ket, United States, Sales Mix (USD Million), 2010 30
Chart 14: Diagnostic Devices March ket, United States, Segment Contribution (%), 2010 31
Chart 15: Diagnostic Devices, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 32
Chart 16: Diagnostic Devices, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 34
Chart 17: Otoscopes, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 36
Chart 18: Otoscopes, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 38
Chart 19: Diagnostic Devices, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 40
Chart 20: Diagnostic Devices, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 42
Chart 21: Otoscopes, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 44
Chart 22: Otoscopes, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 46
Chart 23: Diagnostic Devices, United States, Market Shares (%), 2010 49
Chart 24: Hearing Aid Devices, March ket Segmentation 50
Chart 25: Hearing Aid Devices March ket, United States, Sales Mix (USD Million), 2010 51
Chart 26: Hearing Aid Devices March ket, United States, Segment Contribution (%), 2010 52
Chart 27: Hearing Aid Devices, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 53
Chart 28: Hearing Aid Devices, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 55
Chart 29: Digital Signal Processing Hearing Aids, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 57
Chart 30: Digital Signal Processing Hearing Aids, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 59
Chart 31: Hearing Aid Devices, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 61
Chart 32: Hearing Aid Devices, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 63
Chart 33: Digital Signal Processing Hearing Aids, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 65
Chart 34: Digital Signal Processing Hearing Aids, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 67
Chart 35: Hearing Aid Devices, United States, Market Shares (%), 2010 71
Chart 36: Hearing Implants, March ket Segmentation 73
Chart 37: Hearing Implants March ket, United States, Sales Mix (USD Million), 2010 74
Chart 38: Hearing Implants March ket, United States, Segment Contribution (%), 2010 75
Chart 39: Hearing Implants, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 76
Chart 40: Hearing Implants, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 78
Chart 41: Hearing Implants, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 80
Chart 42: Hearing Implants, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 82
Chart 43: Hearing Implants, United States, Market Shares (%), 2010 85
Chart 44: Nasal Splints, United States, Sales (USD Million), Historical data, from 2003 to 2010 86
Chart 45: Nasal Splints, United States, Sales (USD Million), Forecasted data, from 2010 to 2017 87
Chart 46: Nasal Splints, United States, Volume (Units), Historical data, from 2003 to 2010 88
Chart 47: Nasal Splints, United States, Volume (Units), Forecasted data, from 2010 to 2017 89
Chart 48: Voice Prosthesis, United States, Sales (USD Million), Historical data, from 2003 to 2010 92
Chart 49: Voice Prosthesis, United States, Sales (USD Million), Forecasted data, from 2010 to 2017 93
Chart 50: Voice Prosthesis, United States, Volume (Units), Historical data, from 2003 to 2010 94
Chart 51: Voice Prosthesis, United States, Volume (Units), Forecasted data, from 2010 to 2017 95
Chart 52: Voice Prosthesis, United States, Market Shares (%), 2010 98
Chart 53: Starkey Laboratories, Inc., Market Shares (%),United States ENT Devices March ket, 2010 99
Chart 54: William Demant Holding A/S, Market Shares (%),United States ENT Devices March ket, 2010 100
Chart 55: Sonova Holding AG, Market Shares (%),United States ENT Devices March ket, 2010 101
Chart 56: Cochlear Limited, Market Shares (%),United States ENT Devices March ket, 2010 102
Chart 57: Siemens Healthcare, Market Shares (%),United States ENT Devices March ket, 2010 103
Chart 58: Widex A/S, Market Shares (%),United States ENT Devices March ket, 2010 104Starkey Laboratories, Inc.
William Demant Holding A/S
Sonova Holding AG
Cochlear Limited
Siemens Healthcare
Widex A/S
GN ReSound A/S
MED-EL
Welch Allyn Inc.
Neurelec
Atos Medical AB

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.